Retour
Fourchette du Jour
25,08 €
25,94 €
Fourchette 52 Semaines
19,35 €
66,85 €
Volume
959 805
Moyenne 50J / 200J
28,17 €
/
38,37 €
Clôture Précédente
26,02 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -14,8 | 0,3 |
| P/B | 3,9 | 2,9 |
| ROE % | -24,9 | 3,7 |
| Net Margin % | -31,0 | 3,8 |
| Rev Growth 5Y % | 72,9 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
47,00 €
+87.3%
Low: 30,00 €
High: 62,00 €
BPA Prévisionnel
-1,53 €
CA Est.
400 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
0,41 €
0,38 € – 0,43 €
|
740 M | 5 |
| FY2029 |
-0,33 €
-0,35 € – -0,30 €
|
660 M | 2 |
| FY2028 |
-0,34 €
-1,22 € – 1,43 €
|
590 M | 7 |
Points Clés
Revenue grew 72,90% annually over 5 years — strong growth
Debt/Equity of 0,14 — conservative balance sheet
Negative free cash flow of -58,34M
Revenue growth is decelerating — 1Y growth trails 5Y average by 35,68%
Capital efficient — spends only 3,04% of revenue on capex
Croissance
Revenue Growth (5Y)
72,90%
Revenue (1Y)37,22%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-24,89%
ROIC-18,66%
Net Margin-31,02%
Op. Margin-33,71%
Sécurité
Debt / Equity
0,14
Current Ratio6,85
Interest Coverage-11,69
Valorisation
P/E Ratio
-14,81
P/B Ratio3,87
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 37,22% | Revenue Growth (3Y) | 50,40% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 72,90% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 308,05M | Net Income (TTM) | -95,57M |
| ROE | -24,89% | ROA | -18,81% |
| Gross Margin | 63,70% | Operating Margin | -33,71% |
| Net Margin | -31,02% | Free Cash Flow (TTM) | -58,34M |
| ROIC | -18,66% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,14 | Current Ratio | 6,85 |
| Interest Coverage | -11,69 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -14,81 | P/B Ratio | 3,87 |
| P/S Ratio | 4,59 | PEG Ratio | 10,70 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,42B | Enterprise Value | 1,18B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 308,05M | 224,50M | 136,19M | 75,01M | 34,47M |
| Net Income | -95,57M | -91,41M | -105,90M | -87,15M | -59,85M |
| EPS (Diluted) | -1,72 | -1,75 | -2,24 | -1,96 | -1,37 |
| Gross Profit | 196,23M | 137,10M | 71,05M | 37,09M | 15,87M |
| Operating Income | -103,86M | -96,61M | -109,17M | -80,72M | -54,16M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 508,08M | 534,02M | 404,72M | 309,33M | 337,02M |
| Total Liabilities | 142,21M | 131,80M | 123,97M | 112,26M | 69,93M |
| Shareholders' Equity | 365,87M | 402,22M | 280,75M | 197,07M | 267,09M |
| Total Debt | 51,62M | 80,25M | 79,20M | 77,32M | 54,10M |
| Cash & Equivalents | 286,50M | 333,73M | 257,22M | 222,64M | 304,32M |
| Current Assets | 450,38M | 481,84M | 350,57M | 272,63M | 326,17M |
| Current Liabilities | 65,80M | 53,13M | 45,93M | 35,29M | 16,24M |